The SITC will host the Immune Exclusion Virtual Summit on Monday, Sept. 18, 2023, from 12–5 p.m. EDT. The summit is a free, public event that features invited speakers, expert panel discussions, and attendee question and answer periods. The multi-stakeholder virtual summit will feature over 25 panelists representing academic research and industry from around the world. The SITC Immune Exclusion Virtual Summit will highlight the latest research on the mechanisms of immune exclusion among different tumor types and molecular tools available to study immune-excluded tumors. Topics to be addressed at the summit include the pathology and clinical and therapeutic implications of immune exclusion, mechanisms of immune exclusion, diagnostics for immune exclusion, and current therapeutic strategies for immune exclusion.
The SITC Immune Exclusion Virtual Summit will highlight the current understanding of molecular mechanisms underlying immune exclusion and the tools available to study immune-excluded tumors. This open-door virtual educational event will present the state of the field and feature participation of invited stakeholders involved in this field, including clinicians, pathologists, and researchers from academia and industry.
Immune-excluded tumors, characterized by lymphocytes that surround the tumor but fail to penetrate it, represent about one-third of cancers. The mechanisms underlying immune exclusion remain unclear but may include some combination of physical and/or functional barriers that prevent infiltration of immune cells into the tumor. Defining the unique biology of immune-excluded tumors and elucidating the mechanisms underlying immune exclusion will identify new strategies for cancer immunotherapy, especially in the field of adoptive cellular therapy.
The primary objective of the SITC Immune Exclusion Virtual Summit is to elucidate the molecular mechanisms of immune exclusion in distinct tumor types. Secondary goals include exploring how exclusion biology manifests in different tumor types; reviewing molecular tools available to study immune-excluded tumors; and defining the unique biology of immune-excluded cancers relative to immune-infiltrated and immune-desert tumors.
Meeting: Immune Exclusion Virtual Summit; Date: September 18, 202304:42:46
Meeting: Immune Exclusion Virtual Summit; Date: September 18, 202300:39:13
Meeting: Immune Exclusion Virtual Summit; Date: September 18, 202300:46:11
Meeting: Immune Exclusion Virtual Summit; Date: September 18, 202300:49:56
Meeting: Immune Exclusion Virtual Summit; Date: September 18, 202300:53:44
Meeting: Immune Exclusion Virtual Summit; Date: September 18, 202300:11:37
Meeting: Immune Exclusion Virtual Summit; Date: September 18, 202300:12:10
Meeting: Immune Exclusion Virtual Summit; Speaker: Steven C. Katz, MD, FACS; Date: September 18, 202300:13:59
Meeting: Immune Exclusion Virtual Summit; Date: September 18, 202300:15:34
Meeting: Immune Exclusion Virtual Summit; Speaker: Ryan Sullivan, MD; Date: September 18, 202300:09:46
Meeting: Immune Exclusion Virtual Summit; Speaker: Jakob Kather, MD, MSc; Date: September 18, 202300:09:04
Meeting: Immune Exclusion Virtual Summit; Date: September 18, 202300:20:07
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us